Granules India Plans Rs 2,000 Crore Push into Complex Generics, Oncology and Peptides
Granules India is planning a Rs 2,000 crore investment to drive growth in complex generics, oncology and peptide segments. The plan was reported by The Times of India on 7 October 2026.